Source: Eur Respir J, 49 (6) 1700912; 10.1183/13993003.00912-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sara Roversi, Nathaniel M. Hawkins. Time to move from prognostication to diagnosis and treatment of heart disease in acute exacerbation of COPD. Eur Respir J, 49 (6) 1700912; 10.1183/13993003.00912-2017

Member's Comments

No comment yet.

Related content which might interest you: Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 Copeptin – a marker for differential diagnosis between acute exacerbation of COPD and heart failure in patients with acute dyspnea Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Delay in diagnosis of COPD leading to poor prognosis of disease Source: International Congress 2015 – Different data in COPD Year: 2015 Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007 Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 C-reactive protein at discharge, diabetes mellitus and ≥1 prior hospitalization predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Prolonging the interval to the next acute exacerbations Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Diagnosis and management of heart failure in COPD Source: Eur Respir Mon 2013; 59: 50-63 Year: 2013 Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction Source: International Congress 2014 – Comorbidities Year: 2014 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 55s Year: 2005 Clinical and functional characteristics of patients with acute severe COPD with or without ischemic heart disease Source: Eur Respir J 2006; 28: Suppl. 50, 162s Year: 2006 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016